# A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails

> **NCT07382427** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Onyx Axiom** · enrollment: 200 (estimated)

## Conditions studied

- Onychomycosis of Toenail

## Interventions

- **DRUG:** 2.4% Topical Terbinafine
- **DRUG:** 10% Topical Efinaconazole
- **OTHER:** Vehicle Control

## Key facts

- **NCT ID:** NCT07382427
- **Lead sponsor:** Onyx Axiom
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2028-01
- **Final completion:** 2028-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07382427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07382427, "A Phase 2 Study to Assess the Effectiveness of Topical Terbinafine in Participants With Mild to Moderate Onychomycosis of the Toenails". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT07382427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*